Confronti finanziari Dr. Lal PathLabs Limited

Azioni

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:05:07 13/05/2026			Variaz. 5gg	Var. 1 gen.
1.575,70 ^INR	-0,71%		-0,66%	+6,28%

04/05	Dr. Lal PathLabs Limited: Nomura mantiene la raccomandazione Buy	ZM
01/05	Dr. Lal PathLabs Limited (NSEI:LALPATHLAB) ha perfezionato l'acquisizione di Shahbazkers Diagnostic Centre Private Limited.	CI

Settore:

Regione:

Asse X:

Principali concorrenti

Aggiungi a una lista 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (N-1)	Margine netto (N-1)	Margine EBIT (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
DR. LAL PATHLABS LIMITED	288 Mln	19,79%	22,49%	24,22%	18,83%	-1.45x
NATERA, INC.	2,31 Mrd	-9,03%	-13,44%	-14,32%	-10,26%	3.74x
SONIC HEALTHCARE LIMITED	6,32 Mrd	5,32%	9,43%	6,32%	3,33%	1.63x
RADNET, INC.	2,04 Mrd	-0,91%	3,04%	-	-	1.07x
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	862 Mln	-2,87%	-2,15%	-2,51%	0,5%	-4.19x
DIAN DIAGNOSTICS GROUP CO.,LTD.	1,44 Mrd	0,44%	2,79%	0,68%	0,7%	0.58x
FLEURY S.A.	1,51 Mrd	7,39%	14,73%	11,91%	4,66%	1.46x
VIJAYA DIAGNOSTIC CENTRE LIMITED	79,74 Mln	21%	29,74%	19,7%	-	-0.85x
METROPOLIS HEALTHCARE LIMITED	156 Mln	10,89%	14,6%	11,95%	-	-0.11x
GENEDX HOLDINGS CORP.	428 Mln	-4,92%	9,66%	-	-	-
NEOGENOMICS, INC.	727 Mln	-14,85%	-15,93%	1,71%	-	-
H.U. GROUP HOLDINGS, INC.	1,62 Mrd	1,14%	1,09%	2%	1,66%	1.56x
NOVOGENE CO., LTD.	316 Mln	7,56%	8,76%	6,49%	4,36%	-
BML, INC.	956 Mln	4,37%	6,54%	4,9%	5,72%	-
OPKO HEALTH, INC.	607 Mln	-37,19%	-19,34%	-17,14%	-10,92%	0.19x
THYROCARE TECHNOLOGIES LIMITED	80,44 Mln	-	-	-	-	-
INTEGRAL DIAGNOSTICS LIMITED	411 Mln	0,77%	11,16%	6,35%	2,91%	2.29x
ARTRYA LIMITED	3,6 Mln	-298,73%	-302,59%	-86,14%	-76,86%	0.73x
Media	1,12 Mrd	-17,05%	-12,91%	-1,59%	-4,61%	0,51x
Media ponderata per Capi.	2,23 Mrd	-5,73%	-5,79%	-5,57%	-5,18%	2,20x